Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trends in cryoprecipitate transfusion in the United States.

Transfusion·2026

Same author

Transfusion-transmitted malaria in India: A national survey of epidemiology and testing practices.

Vox sanguinis·2026

Same author

Using blood donor surveillance and clinical case data to shape our understanding of Babesia epidemiology in Manitoba, Canada.

Transfusion·2026

Same author

Long-Term Management of Recurrent Antibody-Induced Bile Salt Export Pump Deficiency After Liver Transplantation Using Therapeutic Plasma Exchange.

Journal of clinical apheresis·2026

Same author

Nationally representative estimates of health care burden of venous thromboembolism in hospitalized cancer patients.

Research and practice in thrombosis and haemostasis·2026

Same author

When Strong Recommendations Rest on Weak Evidence: Lessons From Therapeutic Apheresis Guidelines.

Journal of clinical apheresis·2026

Search research articles

Related Experiment Video

Updated: May 17, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Transfusion-associated microchimerism: the hybrid within.

Evan M Bloch¹, Rachael P Jackman, Tzong-Hae Lee

¹Blood Systems Research Institute, San Francisco, CA 94118, USA. ebloch@bloodsystems.org

Transfusion Medicine Reviews

|October 30, 2012

Summary

This summary is machine-generated.

Transfusion-associated microchimerism (TA-MC) occurs in trauma patients, where donor cells persist long-term. Fresher red blood cells increase TA-MC risk, but no adverse effects are currently known.

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Orthotopic Hind Limb Transplantation in the Mouse

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

Related Experiment Videos

Last Updated: May 17, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Orthotopic Hind Limb Transplantation in the Mouse

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

Area of Science:

Immunology
Cellular Biology
Transfusion Medicine

Background:

Microchimerism, the presence of foreign cells, is known in pregnancy and transplantation.
Transfusion-associated microchimerism (TA-MC) is observed in trauma patients, with donor cells persisting for decades.
TA-MC is likely facilitated by immune alterations following severe trauma.

Purpose of the Study:

To review the current understanding of transfusion-associated microchimerism.
To explore factors influencing TA-MC, including blood product type and storage duration.
To discuss potential clinical implications and future research directions for TA-MC.

Main Methods:

Literature review of studies on microchimerism and transfusion medicine.
Analysis of factors affecting donor cell survival after allogeneic blood transfusion.
Examination of existing data on TA-MC prevalence and clinical outcomes.

Main Results:

TA-MC is documented across various blood products and is not prevented by leukoreduction.
The age of transfused red blood cells is a key predictor, with fresher units posing a higher risk.
No adverse clinical effects have been definitively linked to TA-MC in current studies.

Conclusions:

TA-MC is a distinct phenomenon primarily observed in severely injured patients.
Further research is needed to understand potential links to transfusion-associated graft-versus-host disease and autoimmune conditions.
Microchimerism research offers insights into immune tolerance and has potential diagnostic and therapeutic applications.